Issued Patents 2023
Showing 1–10 of 10 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11845963 | HSD17B13 variants and uses thereof | Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li, Xiping Cheng, Yurong Xin +3 more | 2023-12-19 |
| 11834500 | Bispecific antigen binding molecules that bind leptin receptor and/or GP130, and methods of use thereof | Panayiotis Stevis, Judith Altarejos | 2023-12-05 |
| 11820826 | Anti-NPR1 antibodies and uses thereof | Michael Dunn, Jia SU, Jason Mastaitis, Lori C. Morton | 2023-11-21 |
| 11779633 | Glucagon-like peptide 1 receptor agonists and uses thereof | Yang Wei, Haruka Okamoto, Samuel Davis, Andrew J. Murphy | 2023-10-10 |
| 11753628 | HSD17B13 variants and uses thereof | Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li, Xiping Cheng, Yurong Xin +3 more | 2023-09-12 |
| 11730150 | Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy | Charleen Hunt, Jason Mastaitis, Guochun Gong, Ka-Man Venus Lai, Aris N. Economides | 2023-08-22 |
| 11708416 | Methods of treating severe insulin resistance by interfering with glucagon receptor signaling | Haruka Okamoto, Stephen R. Jaspers, Joyce Harp | 2023-07-25 |
| 11702700 | Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation | Yurong Xin, Xiping Cheng, Frederick Dewey, Tanya Teslovich Dostal, Claudia Schurmann +2 more | 2023-07-18 |
| 11642390 | Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody | Panayiotis Stevis, Andrew J. Murphy, Yonaton Ray, Jee H. Kim, Ivan B. Lobov | 2023-05-09 |
| 11608381 | Methods of treatment using a leptin receptor agonist antibody | Panayiotis Stevis, Judith Altarejos, Andrew J. Murphy | 2023-03-21 |